Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 390 Carboplatin 344 pembrolizumab 331 Gemcitabine 331 Cisplatin 327 Paclitaxel 295 Radiotherapy 292 Docetaxel 287 Bevacizumab 250 Rituximab 233 Capecitabine 222 Nivolumab 220 Dexamethasone 205 Fluorouracil 190 fludarabine 178 Oxaliplatin 178 Pemetrexed 154 Doxorubicin 152 Irinotecan 148 Leucovorin 144 Etoposide 144 Cytarabine 134 fludarabine phosphate 129 Bortezomib 129 Cetuximab 128 Lenalidomide 125 Filgrastim 120 Erlotinib Hydrochloride 120 Temozolomide 111 Ipilimumab 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Association × Clear all

NCT01613482 2026-03-16

TSARINE

Centre Oscar Lambret

Phase 3 Terminated

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡